Nektar Therapeutics reported $138.52M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 89.16M 66K
ALKERMES ALKS:US 313.8M 14.5M
Amgen AMGN:US $ 4.33B 1.37B
Astrazeneca AZN:US 11.54B 4.45B
Baxter International BAX:US $ 2731M 57M
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Biogen BIIB:US $ 1984.9M 304.4M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Cara Therapeutics CARA:US $ 21.4M 9.48M
Dr.Reddys Laboratories DRRD:IN 47.21B 2.27B
Eisai 4523:JP Y 157959M 14472M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Esperion Therapeutics ESPR:US $ 70.15M 3.04M
Exelixis EXEL:US $ 276.8M 14.63M
Gilead Sciences GILD:US $ 3579M 392M
GlaxoSmithKline GSK:LN 7.14B 722M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Immunogen IMGN:US $ 43.44M 873K
IONIS PHARMACEUT IONS:US $ 219M 11.65M
Ironwood Pharmaceuticals IRWD:US $ 38.58M 0.36M
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Macrogenics MGNX:US $ 68.65M 2.39M
Merk MRK:US $ 8328M 1460M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novartis NOVN:VX 10.13B 319M
Pfizer PFE:US $ 16447M 3384M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Seattle Genetics SGEN:US $ 722.02M 243.94M
Takeda 4502:JP 747.39B 46.34B
Teva Pharmaceutical TEVA:IT 3.26B 64M
Xencor XNCR:US $ 61.58M 3.22M
YTE INCY:US $ 577.58M 12.7M